Neeta Pandit-Taskar, MD

Attending, Molecular Imaging and Therapy Service, Department of Radiology; Member, Memorial Hospital; Professor, Dept. of Radiology, Weill Cornell; Clinical Director, Center for Radioimmunotargeted Imaging and Theranostics of the Ludwig Center for Cancer
The Steven Larson Lab
Research Overview
Projects
Featured News
Publications
Open Positions

Neeta Pandit-Taskar, MD

Attending, Molecular Imaging and Therapy Service, Department of Radiology; Member, Memorial Hospital; Professor, Dept. of Radiology, Weill Cornell; Clinical Director, Center for Radioimmunotargeted Imaging and Theranostics of the Ludwig Center for Cancer
Share
Share
Neeta Pandit-Taskar

Projects & Research Focus

Radioimmunotargeted imaging and theranostics; Theranostics of pediatric tumors including neuroblastoma and other adult solid tumors; multistep radioimmunotargeting; novel strategies of radioimmunotargeting; Therapy with alpha emitters.

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Neeta Pandit-Taskar discloses the following relationships and financial interests:

  • Actinium
    Professional Services and Activities
  • Fusion Pharmaceuticals Inc.
    Professional Services and Activities (Uncompensated)
  • Illumina
    Professional Services and Activities (Uncompensated)
  • ImaginAb
    Professional Services and Activities (Uncompensated)
  • Progenics
    Professional Services and Activities
  • Y-mAbs Therapeutics, Inc.
    Professional Services and Activities (Uncompensated)

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures